Skip to content

A Multicenter Cohort Study of the Efficacy between Posterior Laminoplasty, Laminectomy and Laminectomy with mass Screw Fixation in Treatment of Cervical Ossification in Posterior Longitudinal Ligament(OPLL)

A Multicenter Cohort Study of the Efficacy between Posterior Laminoplasty, Laminectomy and Laminectomy with mass Screw Fixation in Treatment of Cervical Ossification in Posterior Longitudinal Ligament(OPLL)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016624
Enrollment
Unknown
Registered
2018-06-13
Start date
2018-08-01
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ossification of Posterior Longitudinal Ligament ( OPLL )

Interventions

Group A:Underwent Posterior Laminoplasty
Group B:Underwent Posterior Laminectomy
Group C:Underwent Posterior Laminectomy with Fixation

Sponsors

Changzheng Hospital, Second Militray Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1) patients aged 18-65 years, without gender limitation, are willing to sign informed consent; 2) patients diagnosed with OPLL,CT showed that the compression of the posterior longitudinal ligament ossification involve more than 3 spinal segments; 3) patients presented with limbs numbness, walking instability, or other spinal cord, nerve root compression symptoms, which may be associated with OPLL;4)Conservative treatment is invalid.

Exclusion criteria

Exclusion criteria: 1) Cervical ligamentous ossification, cervical trauma, cervical cancer, cervical tuberculosis and other inflammatory diseases; 2) accompanied by other spine parts of the disease affect the clinical symptoms of patients; 3) associated with amyotrophic lateral sclerosis and other motor neuron diseases and other neurological diseases; 4) poor health condition, unable to tolerate surgery; 5) patients (or their guardians) can not give full informed consent for adult dysfunction; 6) patients who have participated in other clinical trials in the past 1 month; 7) patients with active hepatitis B (including HBeAg) or serological markers (HBsAg or / and HBeAg or / and HBcAb), hepatitis C, tuberculosis, cytomegalovirus infection, severe fungal infection, HIV infection or patients with Turmor.

Design outcomes

Primary

MeasureTime frame
JOA score;shift of posterior margin of the spinal cord;

Secondary

MeasureTime frame
Neck disability index;visual analogue scale(VAS);curvature index (CI);Incidence rate of C5 root palsy;time of operation;

Countries

China

Contacts

Public ContactGuohua Xu

Department of Orthopaedic Surgery, The spine surgical center, Changzheng Hospital, Second Militray Medical University

xuguohuamail@smmu.edu.cn+86 13386279098

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026